Drug class
IgG-cleaving enzyme; selective immunosuppressant
Mechanism of action
A cysteine protease derived from Streptococcus pyogenes that cleaves the heavy chains of human IgG, rapidly reducing donor-specific IgG antibodies and Fc-mediated effector activity.
General use cases
- Desensitisation of highly sensitised adult kidney-transplant candidates with a positive crossmatch against an available deceased donor, under the authorised product indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
